Difference between revisions of "Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5 (Q9934)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 16, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM (English) | ||
| Property / title: Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:06, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Deng Zhenling
0 references
Wu Yanhong
0 references
Ma Wenbo
0 references
1
0 references
2015
0 references
BMC Immunology
0 references
16
0 references
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM (English)
0 references
